, Guidelines for the treatment of malaria, 2010.
, WHO. Global Malaria Programme. World Malaria Report, 2014.
, Guidelines for the treatment of malaria, 2015.
In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon, Antimicrob Agents Chemother, vol.42, pp.2347-51, 1998. ,
In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs, Antimicrob Agents Chemother, vol.43, pp.418-438, 1999. ,
Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali, Int J Parasitol, vol.38, pp.791-799, 2008. ,
A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs, Malar J, vol.12, p.450, 2013. ,
Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia, Malar J, vol.10, p.268, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00629634
In vivo selection of Plasmodium falciparum pfmdr1 86 N coding alleles by artemether-lumefantrine (Coartem), J Infect Dis, vol.191, pp.1014-1021, 2005. ,
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa, Trop Med Int Health, vol.12, pp.736-778, 2007. ,
Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda, J Infect Dis, vol.204, pp.1120-1124, 2011. ,
Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria, Antimicrob Agents Chemother, vol.53, pp.888-95, 2009. ,
Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria, Antimicrob Agents Chemother, vol.51, pp.991-998, 2007. ,
Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine, Antimicrob Agents Chemother, vol.55, pp.5408-5419, 2011. ,
Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in thai isolates of Plasmodium falciparum, Am J Trop Med Hyg, vol.83, pp.1005-1014, 2010. ,
Synergism of benflumetol and artemether in Plasmodium falciparum, Am J Trop Med Hyg, vol.61, pp.439-484, 1999. ,
Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.361, pp.455-67, 2012. ,
Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism, Antimicrob Agents Chemother, vol.54, pp.1872-1879, 2010. ,
Evidence of artemisinin-resistant malaria in western Cambodia, N Engl J Med, vol.359, pp.2619-2639, 2008. ,
Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in Western Cambodia, Antimicrob Agents Chemother, vol.57, pp.914-937, 2013. ,
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drug-response studies, Lancet Infect Dis, vol.13, pp.1043-1052, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00863935
Flow cytometry-based analysis of artemisinin-resistant Plasmodium falciparum in the ring-stage survival assay, Antimicrob Agents Chemother, vol.58, pp.4938-4978, 2014. ,
Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia, Proc Natl Acad Sci USA, vol.110, pp.240-245, 2013. ,
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.505, pp.50-55, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00921203
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial, Lancet, vol.372, pp.1819-1846, 2008. ,
In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique, Malar J, vol.13, p.309, 2014. ,
Randomized, multicentre assessment of the efficacy and safety of ASAQ-a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria, Malar J, vol.8, p.125, 2009. ,
Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia, Malar J, vol.5, p.75, 2006. ,
Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo, Malar J, vol.5, p.113, 2006. ,
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali, Am J Trop Med Hyg, vol.79, pp.655-61, 2008. ,
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, Am J Trop Med Hyg, vol.75, pp.630-636, 2006. ,
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial, Lancet Infect Dis, vol.16, pp.189-98, 2015. ,
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique, Antimicrob Agents Chemother, vol.16, pp.710-718, 1979. ,
,
A molecular marker for chloroquine-resistant falciparum malaria, N Engl J Med, vol.344, pp.257-63, 2001. ,
Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara. Mali, Am J Trop Med Hyg, vol.92, pp.1202-1208, 2015. ,
In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes, Int J Parasitol, vol.38, pp.743-750, 2008. ,
Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs, Malar J, vol.10, p.310, 2011. ,
Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season, Malar J, vol.14, p.60, 2015. ,
DOI : 10.1186/s12936-015-0589-3
URL : https://hal.archives-ouvertes.fr/hal-01220028
In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand, Wien Klin Wochenschr, vol.116, pp.41-47, 2004. ,
Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial, Malar J, vol.11, p.364, 2012. ,
No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali, Am J Trop Med Hyg, vol.87, pp.23-31, 2012. ,
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study, Malar J, vol.13, p.33, 2014. ,
In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso, Antimicrob Agents Chemother, vol.59, pp.734-741, 2015. ,
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin, Antimicrob Agents Chemother, vol.58, pp.7032-7072, 2014. ,
Increased prevalence of the Plasmodium falciparum Pfmdr1 86 N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine, Infect Genet Evol, vol.11, pp.512-519, 2011. ,
Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy, Malar J, vol.12, p.377, 2013. ,
Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study, J Infect Dis, vol.211, pp.680-688, 2015. ,
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine, Am J Trop Med Hyg, vol.91, pp.833-876, 2014. ,